510(k) Report

510(k) · Cleared

Cleared

Quickvue Influenza a/B Test

K991633510(k) TraditionalCleared Sep 24, 1999135-day reviewClass II21 CFR 866.3328

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quidel Corp. · PSZ Devices Detecting Influenza A, B, And C Virus Antigens

Cleared on Sep 24, 1999 after a 135-day review. The FDA summary names its predicate without a number. 46 later devices descend from it.

Decided
Sep 24, 1999
Review
135 days
Class
Class II
Product code
PSZ
Recalls
None
Predicates
0

46 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared2002: 2 descendants cleared2005: 3 descendants cleared2004: 3 descendants cleared2009: 4 descendants cleared2006: 2 descendants cleared2010: 3 descendants cleared2012: 3 descendants cleared2011: 1 descendant cleared2013: 7 descendants cleared2007: 2 descendants cleared2015: 4 descendants cleared2016: 2 descendants cleared2018: 2 descendants cleared2023: 2 descendants cleared2017: 2 descendants cleared2020: 1 descendant cleared2025: 1 descendant cleared2026: 1 descendant cleared1995200020052010201520202025
  1. This deviceK991633 Quickvue Influenza a/B TestQuidel Corp. · 1999
  2. Descendant · cites it directly · 34 of its ownK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
  3. Descendant · cites it directly · 27 of its ownK053146 Quickvue Influenza a + B TestQuidel Corp. · 2005
  4. Descendant · 2 generations on · 24 of its ownK092698 Quickvue Influenza a+B TestQuidel Corp. · 2009
  5. Descendant · 2 generations on · 20 of its ownK112277 BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · Recalled
  6. Descendant · 3 generations on · 19 of its ownK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013

Showing 5 of 46 descendants. See all descendants

Descendants cleared per year

2002: 22003: 12004: 32005: 32006: 22007: 22009: 42010: 32011: 12012: 32013: 72015: 42016: 22017: 22018: 22020: 12023: 22025: 12026: 1
2002high 7 (2013) · low 0 (2008)2026

Most influential descendants

Showing 5 of 46 · See all
  • K031899Quickvue Influenza a+B TestQuidel Corp. · 2003 · cites it directly34descendants
  • K053146Quickvue Influenza a + B TestQuidel Corp. · 2005 · cites it directly27descendants
  • K092698Quickvue Influenza a+B TestQuidel Corp. · 2009 · 2 generations on24descendants
  • K112277BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · 2 generations on20descendants
  • K132259BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013 · 3 generations on19descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K991633Quickvue Influenza a/B TestQuidel Corp.1999—
+1K031899Quickvue Influenza a+B TestQuidel Corp.2003—
+1K053146Quickvue Influenza a + B TestQuidel Corp.2005—
+2K092698Quickvue Influenza a+B TestQuidel Corp.2009—
+2K112277BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company20111
+3K132259BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company2013—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200220
200310
200430
200530
200620
200720
200940
201030
201110
201230
201370
201540
201620
201720
201820
202010
202320
202510
202610
FIG. 1 — Lineage of K991633, 1999–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSZ device

  1. #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—viral culture
Named without a submission number
—

What descends from it? (46)

See all 46

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K031899Quickvue Influenza a+B TestQuidel Corp.200334
K053146Quickvue Influenza a + B TestQuidel Corp.200527
K021649Binax Now Flu a Test (27 Test), Binax Now Nasopharyngeal Swab Specimen Accesory PackBinax, Inc.200211
K021646Binax Now Flu B Test (27 Test), Binax Now Nasopharyngeal Swab Specimen Accesory PackBinax, Inc.20027

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K031899 (Quidel Corp., 2003) has gone furthest, with 34 descendants of its own.

How does its category compare?

All PSZ devices

PSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · PSZ

2in 2025

2007: 22008: 12009: 72010: 52011: 32012: 22013: 82014: 12015: 42016: 32017: 32018: 52020: 22023: 22025: 22026 (partial year): 2
2007high 8 (2013) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSZ

28in 2018

2009: 20 days median2010: 29 days median2011: 80 days median2013: 28 days median2015: 27 days median2016: 29 days median2017: 200 days median2018: 28 days median
2007high 200 (2017) · low 20 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSZ

1in 2022

2020: 12022: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSZ

60in 2025

2018: 12019: 12020: 52021: 422022: 102023: 122024: 162025: 60
2007high 60 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200972000
201052900
201138000
20122—00
201382800
20141—00
201542700
201632900
2017320000
201852801
20190—01
20202—15
20210—042
20220—110
20232—012
20240—016
20252—060
20262—0—

What is it indicated for?

The QuickVue Influenza A/B Test is intended for the qualitative detection of influenza Type A and Type B antigens directly from nasal swab, nasal wash and nasal aspirate specimens. The QuickVue Influenza A/B Test is intended for laboratory and professional use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991633: Quickvue Influenza a/B Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991633

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026